{{Rsnum
|rsid=1049216
|Gene=CASP3
|Chromosome=4
|position=184628935
|Orientation=minus
|GMAF=0.4036
|Gene_s=CASP3
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{PMID Auto
|PMID=23765963
|Title=HuGE systematic review and meta-analysis demonstrate association of CASP-3 and CASP-7 genetic polymorphisms with cancer risk
}}

{{PMID Auto
|PMID= 17071630
|Title=Genetic variants in caspase genes and susceptibility to non-Hodgkin lymphoma.
}}
[[rs1049216]] is a [[SNP]] that has been found to significantly decrease the Non-Hodgkin Lymphoma.

{{PMID Auto
|PMID=18381704
|Title=Caspase polymorphisms and genetic susceptibility to multiple myeloma.
|OA=1
}}

{{PMID Auto
|PMID=18520591
|Title=Sequence variants in host cell factor C1 are associated with Meniere's disease.
|OA=1
}}

{{PMID Auto
|PMID=18829519
|Title=CASP3 polymorphisms and risk of squamous cell carcinoma of the head and neck.
|OA=1
}}

{{PMID Auto
|PMID=19531679
|Title=Polymorphisms and haplotypes in the caspase-3, caspase-7, and caspase-8 genes and risk for endometrial cancer: a population-based, case-control study in a Chinese population.
|OA=1
}}

{{PMID Auto
|PMID=19938081
|Title=Altered transmission of HOX and apoptotic SNPs identify a potential common pathway for clubfoot.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}